Valuation: Winston Pharmaceuticals, Inc.

Market Cap	15.48M 13.89M 12.69M 11.58M 21.83M 1.46B 22.51M 153M 60.99M 777M 58.11M 56.86M 2.45B	P/E 2008	-49.9x	P/E 2009	-6.46x
Enterprise Value	13.92M 12.48M 11.41M 10.41M 19.62M 1.31B 20.24M 138M 54.84M 698M 52.24M 51.12M 2.2B	EV / Sales 2008	572x	EV / Sales 2009	14.4x
Free-Float	100%	Yield 2008 *	-	Yield 2009	-

* Estimated data More valuation ratios

Chart: Winston Pharmaceuticals, Inc.

Dynamic Chart

Latest news: Winston Pharmaceuticals, Inc.

09/04/12

Winston Pharmaceuticals, Inc. Receives SBIR Grant from the NIH to Investigate Treatment for Postherpetic Neuralgia of the Trigeminal Nerve

More news

Managers and Directors: Winston Pharmaceuticals, Inc.

Manager	Title	Age	Since
Joel E. Bernstein CEO	Chief Executive Officer	83	19/02/2010

More insiders

Winston Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company discovers, develops and commercializes therapeutics for managing and alleviating pain. The Company's late stage candidates include products for the treatment of episodic cluster headache, chronic migraine headache, osteoarthritis, rheumatoid arthritis, neuropathic pain, and pain and inflammation in inflammatory bowel disease. The Company is developing Civamide, which is a transient receptor potential channels vanilloid-1 (TRPV-1) modulator in different dosage forms for several different pain indications. The Company's other products are under development for the treatment of headache and neuropathic and rheumatological pain.

Employees

Sector

Pharmaceuticals

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Delayed OTC Markets 21:34:44 29/04/2026 +03			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		-.--%	-

Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.3
10 years	0		0.3

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WINSTON PHARMACEUTICALS, INC.	-99.00%	-.--%	-	-	77
ELI LILLY AND COMPANY	-0.11%	-3.69%	+45.64%	+129.39%	1,216B
JOHNSON & JOHNSON	+1.11%	+0.63%	+47.04%	+81.23%	656B
ABBVIE INC.	+0.78%	-1.67%	+32.38%	+105.36%	509B
ROCHE HOLDING AG	-0.36%	-3.25%	+47.17%	+64.58%	384B
MERCK & CO., INC.	-0.14%	-1.91%	+70.97%	+40.56%	362B
NOVARTIS AG	-0.78%	-0.52%	+30.57%	+57.98%	311B
ASTRAZENECA PLC	-0.80%	-0.21%	+8.54%	+35.56%	293B
AMGEN INC.	+0.27%	-1.14%	+45.97%	+68.85%	249B
GILEAD SCIENCES, INC.	+0.29%	-1.50%	+36.24%	+107.20%	208B
Average	-9.96%	+0.54%	+40.50%	+76.75%	418.78B
Weighted average by Cap.	+0.03%	+0.03%	+42.41%	+88.73%

	2008	2009
Net sales	453K 406K 371K 339K 638K 42.54M 658K 4.47M 1.78M 22.7M 1.7M 1.66M 71.66M	1.39M 1.25M 1.14M 1.04M 1.97M 131M 2.03M 13.78M 5.49M 69.95M 5.23M 5.12M 221M
Net income	-5.14M -4.61M -4.21M -3.85M -7.25M -483M -7.48M -50.8M -20.26M -258M -19.3M -18.89M -814M	-2.66M -2.38M -2.18M -1.99M -3.74M -250M -3.86M -26.23M -10.46M -133M -9.97M -9.75M -420M
Net Debt	-5.63M -5.05M -4.61M -4.21M -7.93M -529M -8.18M -55.59M -22.17M -282M -21.12M -20.67M -891M	-1.56M -1.4M -1.28M -1.17M -2.2M -147M -2.27M -15.44M -6.16M -78.39M -5.87M -5.74M -247M

Winston Pharmaceuticals, Inc. Stock

Stocks

WPHM

US9756571074

Pharmaceuticals

Valuation: Winston Pharmaceuticals, Inc.

Chart: Winston Pharmaceuticals, Inc.

Latest news: Winston Pharmaceuticals, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Winston Pharmaceuticals, Inc.

Other Pharmaceuticals

Financials

Company Profile